Loss of caveolin-1 from bronchial epithelial cells and monocytes in human subjects with asthma.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 23004679.
- Also identified by DOI 10.1111/all.12021 and PMC identifier 3499648.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Caveolin-1 has emerged as a critical regulator of signaling pathways involved in lung fibrosis and inflammation. Therefore, we investigated whether caveolin-1 is deficient in asthmatic patients and in a murine model of asthma. Immunohistochemical analyses of endobronchial biopsies showed a remarkable loss of caveolin-1 in the lungs of asthmatic patients compared with controls. This loss was most evident in bronchial epithelial cells and associated with an increase in the expression of extracellular matrix proteins: collagen I, tenascin, and periostin. Cultured primary bronchial epithelial cells of asthmatics had lower caveolin-1 expression compared with control cells. In addition, caveolin-1 expression was significantly decreased in peripheral blood monocytes from asthma patients. The loss of caveolin-1 was also observed in a mouse model for asthma (mice sensitized and challenged with aspergillus fumigatus). To our knowledge, this is the first demonstration that the regulatory protein caveolin-1 is reduced in patients with asthma.
Medical subject headings
- Asthma
- Bronchi
- Caveolin 1
- Epithelial Cells
- Monocytes